Abstract
Summary
Sodium amylosulfate (SAS), a new anticoagulant, was found to interfere with the antibacterial activity of blood and serum. This agent permitted recovery of 1 organism/ml from artificially inoculated blood, whereas over 104 organism/ml were required without SAS. At least two fractions were involved in the bacteriocidal properties of serum. One was heat labile and the other heat stable. Both were eliminated by treatment with SAS.
Get full access to this article
View all access options for this article.